Reckitt Benckiser Group plc (RBGLY)

OTC Markets OTCQX • Currently down 0.20 (-1.55%) in today's trading session

1 member of Congress has disclosed 3 trades in Reckitt Benckiser Group plc (RBGLY) via STOCK Act filings. The most recent disclosure was a sale by Mikie Sherrill on 28 May 2019. Aggregate disclosed activity totals roughly $8K in purchases and $16K in sales (midpoint estimates from bracketed disclosure amounts).

Reckitt Benckiser Group plc is currently trading at $12.70, positioned at 8% of its 52-week range ($12.27 – $17.80).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Copy PortfolioClaim Free Asset
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$12.70
24h Change
-0.20 (-1.55%)
52 Week Range
$12.27—$17.80
View on NASDAQ

Reckitt Benckiser Group plc Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for RBGLY

Select to highlight on chart
1 transactions
Compliance: 33%
Mikie Sherrill28 May 20198 Jul 2019SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$40.99B

Volume

31.57K

Beta

0.25

P/E Ratio

9.69

Fundamentals

EPS

$1.31

Div. Yield

9.49%

Open

$12.79

Day Range

$12.66 — $12.82

Company Information

Sector
Consumer Defensive
Industry
Household & Personal Products
Exchange
OTC · USD
Country
GB
CEO
Kristoffer Loe Licht
IPO Date
2008-10-15
Website
www.reckitt.com

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disin...

Earnings

Next Report

Q2 2026

29 Jul

EPS Est.

$0.42

Rev. Est.

$8.4B

Days Until

64

Recent Quarters

Q4 20255 Mar
EPS$0.50
Beat 0.0%
Q1 202530 Jun
EPS$0.38
Miss 13.9%
Q3 202431 Dec
EPS$0.10
Miss 74.1%
Q1 202430 Jun
EPS$0.41
Beat 3.3%
Q3 202331 Dec
EPS$0.14
Miss 61.6%
Q1 202330 Jun
EPS$0.43
Beat 0.7%
Q3 202231 Dec
EPS$0.34
Miss 17.4%
Q2 202227 Jul
EPS$0.46
Beat 26.8%
Q1 202229 Apr
EPS$0.64
Beat 59.5%
Q3 202126 Oct
EPS$-0.67
Miss 269.5%
Q3 202031 Dec
EPS$0.04
Miss 90.4%
Q3 202020 Oct
EPS$0.38
Miss 13.4%
Q1 202030 Apr
EPS$-1.37
Miss 382.8%
Q2 201930 Jul
EPS$0.04
Q1 20192 May
EPS$0.49
Q2 201827 Jul
EPS$0.32
Q4 201719 Feb
EPS$0.98
Q3 201718 Oct
EPS$0.28
Q1 201721 Apr
EPS$0.43
Q3 201619 Oct
EPS$0.18
Q1 20163 Jun
EPS$0.42
Q3 201521 Oct
EPS$0.30
Q4 201411 Feb
EPS$0.44
Q3 201414 Nov
EPS$0.31
Q1 201416 Apr
EPS$0.48
Q1 201330 Jun
EPS$0.28
Q3 201231 Dec
EPS$0.45
Q1 201230 Jun
EPS$0.33
Q3 201131 Dec
EPS$0.39
Q1 201130 Jun
EPS$0.31
Q3 201031 Dec
EPS$0.35
Q1 201030 Jun
EPS$0.31
Q3 200931 Dec
EPS$0.35
Q1 200930 Jun
EPS$0.28
Q3 200831 Dec
EPS$0.19
Q1 200830 Jun
EPS$0.13
Q3 200731 Dec
EPS$0.15
Q1 200730 Jun
EPS$0.36
Q3 200631 Dec
EPS$0.18
Q1 200630 Jun
EPS$0.17
Q3 200531 Dec
EPS$0.15
Q1 200530 Jun
EPS$0.16
Q3 200431 Dec
EPS$0.15
Q1 200430 Jun
EPS$0.14
Q3 200331 Dec
EPS$0.11
Q1 200330 Jun
EPS$0.11
Q3 200231 Dec
EPS$0.08
Q1 200230 Jun
EPS$0.08

Dividends

Dividend History

10 Apr 2026
Amount $0.3348
2 Feb 2026
Amount $0.6310
8 Aug 2025
Amount $0.2390
11 Apr 2025
Amount $0.3164
5 Aug 2024
Amount $0.2169
11 Apr 2024
Amount $0.3066
4 Aug 2023
Amount $0.2065
10 Apr 2023
Amount $0.2763
5 Aug 2022
Amount $0.1835
28 Apr 2022
Amount $0.2784
5 Aug 2021
Amount $0.2106
6 May 2021
Amount $0.2909
20 Aug 2020
Amount $0.1992
16 Apr 2020
Amount $0.2649
22 Aug 2019
Amount $0.1856
22 Apr 2019
Amount $0.2753
16 Aug 2018
Amount $0.1929
12 Apr 2018
Amount $0.2847
16 Aug 2017
Amount $0.1814
13 Apr 2017
Amount $0.2461
17 Aug 2016
Amount $0.1616
13 Apr 2016
Amount $0.2638
12 Aug 2015
Amount $0.1637
15 Apr 2015
Amount $0.2513
6 Aug 2014
Amount $0.2059
19 Feb 2014
Amount $0.2597
7 Aug 2013
Amount $0.1856
20 Feb 2013
Amount $0.2455
9 Aug 2012
Amount $0.1775
22 Feb 2012
Amount $0.2242
3 Aug 2011
Amount $0.1826
23 Feb 2011
Amount $0.2120
4 Aug 2010
Amount $0.1562
24 Feb 2010
Amount $0.1805
5 Aug 2009
Amount $0.1430
25 Feb 2009
Amount $0.1379

Stock Splits

Split History

2 Feb 2026Reverse Split
Ratio24:25
31 Dec 2014Stock Split
Ratio257:250

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about RBGLY

Which members of Congress have traded RBGLY?
1 member of Congress has disclosed 3 trade in Reckitt Benckiser Group plc (RBGLY) under the STOCK Act: Mikie Sherrill.
When was RBGLY most recently disclosed by Congress?
The most recent RBGLY disclosure was a sale by Mikie Sherrill on 28 May 2019.
What is the total disclosed congressional trading volume for RBGLY?
Members of Congress have disclosed approximately $8K in RBGLY purchases and $16K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in RBGLY?
This RBGLY page updates as soon as new STOCK Act disclosures are filed for Reckitt Benckiser Group plc. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
Follow on XJoin our Discord
PoliticiansBillsPortfoliosPricingLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.